A n important portion of psychotherapy patients have a prior history of in-or outpatient treatment. Substance abusers, for instance, often undertake more than one treatment attempt. Among patients suffering from eating disorders, repeated psychotherapy experiences are more often a rule than an exception. 1 Psychotherapy history, together with a diagnosis of obsessive-compulsive disorder, predicted high-intensive use of mental health services among anxious patients. 2 Comorbidity and concomitant personality disorders are known factors related to more extensive histories of psychiatric treatment. 3 Further, previous psychotherapy experience can affect attitudes toward future treatments. In a sample of elderly patients suffering from depression, the degree of satisfaction with prior psychotherapy was associated with current preference for psychotherapy over pharmacological treatment. 4 Among patients with anxiety disorders, those with psychotherapy history in the past 5 years rated pharmacological treatment (but not psychotherapy) as more credible, compared with patients without recent psychotherapy history. 5 Similarly, a positive effect of treatment history was found among parents of children with anxiety regarding medication treatment, but not regarding cognitive-behavioural therapy. 6 Available up-to-date empirical data does not allow for a firm conclusion on whether and how prior psychotherapy experience affects the course of future treatments. In a sample of 148 female sexual abuse survivors undergoing group therapy, those with previous psychotherapy experience achieved greater pre-posttreatment changes on the SCL-90. 7 Similar findings are reported for long-term group therapy, where dropouts were more likely to have no previous experience of psychotherapy, and more often had an Axis II diagnosis than treatment completers. 8 However, a recent study 9 on several thousand patients receiving behavioural health treatment did not confirm prior outpatient treatment history as a factor influencing outcome. Among patients with anxiety disorders being treated with cognitive-behavioural therapy, equivalent shortand long-term improvement was observed for those with or without therapy history in the last 5 years. 5 One possible explanation for the inconsistent research literature on this matter is that, rather than prior psychotherapy itself, the degree of satisfaction with prior psychotherapy attempts may have a differential impact on the course of future treatments. One study provided positive results in this direction: substance abuse patients with successful treatment histories showed improved cocaine abstention after a 14-week cognitive-behavioural therapy program and marginally better attendance than patients with negative psychotherapy experiences. 10 Based on these findings, it may be worth differentiating between patients perceiving prior therapy as helpful, and those rating it as unhelpful. Comparisons of these 2 groups, with the group of patients seeking treatment for the first time, may lead to more consistent results regarding whether the variable therapy experience affects the benefit of future treatments.
Moreover, the inclusion of process variables highlighting possible mechanisms through which patients with different experiences may achieve more or less favourable outcomes has been neglected in past studies. Findings on whether and how such variables predict psychotherapy outcome would have strong implications for clinical practice as they could assist therapists in detecting patients with less favourable pretreatment conditions. This would allow the planning of additional interventions such as specific pretreatment training.
Our main purpose was to examine the patterns of past psychotherapy experience in a sample of patients with social anxiety disorder and to analyze how this variable affects the course of cognitive-behavioural group therapy. Patients with a previous history of psychiatric treatment (especially a negative one) were expected to have more severe initial symptomatology than first-time therapy patients. The second hypothesis was that patients with negative psychotherapy experiences in the past would reach poorer outcomes, compared with patients who rated previous treatments as effective and with those without psychotherapy experience. Finally, the differential effect of prior psychotherapy history on actual outcome as a function of the process variable therapy engagement was explored.
Method

Sample
Study subjects were 57 consecutive outpatients (49% women) undergoing cognitive-behavioural group treatment for social anxiety disorder. All participants met DSM-IV criteria for social phobia and had LSAS intake scores within the social phobia range (mean 69, SD 26). 11 The average age was 35 years (SD 11). A minority of patients (n = 11, 19%) had no previous psychotherapy experience; 61% (n = 28) of those who had been in therapy before rated previous treatment as helpful, and 49% (n = 18) as not helpful. About one-half of the patients (n = 29, 51%) sought group therapy on their own initiative; 21 patients (37%) were referred by an external psychotherapist; and the rest were referred by a primary care physician (n = 5, 9%) or by a family member (n = 2, 3%).
Eight patients (14%) terminated group therapy prematurely after a mean of 2.1 sessions (SD 1.5). Posttreatment assessments were completed by 47 patients. In terms of pretreatment variables, no significant differences were found between patients with missing data and those who completed all the assessments.
Intervention
Treatment consisted of 10 sessions of cognitive-behavioural group therapy for social anxiety disorder over a 3-month period (the first 5 sessions weekly, sessions 6 to 10 on alternating weeks). Sessions lasted 90 minutes and there were 6 to 8 participants in each group.
The multimodal manualized treatment was based on the approaches of Hope et al 12, 13 and on the evaluation of previous group therapies, 14, 15 and is routinely held at our Anxiety Disorders Unit in Zurich, Switzerland. The main components of the group treatment included: applying the cognitivebehavioural model for social anxiety disorder to typical situations experienced by the patients; graded in-session exposures to feared social interactions (for example, role playing of real situations, video feedback, or shifting attention outward) and individualized exposures in real life and in vivo exposures in town; addressing misconceptions of social situations and, based on new experiences, cognitive restructuring by identifying and challenging dysfunctional schemas (for example, unrelenting standards or abandonment schemas); developing personal strategies and identifying resources; planning of realistic goals for the time after therapy; and relapse prevention.
Group therapy was delivered by 3 cognitive-behavioural therapists (2 clinical psychologists and one psychiatrist), all of whom had extensive prior experience with group therapy for anxiety disorders. Each group was led by 2 of the 3 therapists.
Measures
Prior Psychotherapy Experience. Patients were asked to answer the following 2 questions with a yes or no answer: "Have you been in psychotherapy before?"; "If yes, was psychotherapy helpful to you?"
Anxiety. The self-rating version of the LSAS 11 was administered for assessing social anxiety and avoidance in typical social situations. The total score ranges from 0 to 144. General anxiety levels were measured with the BAI. 16 Self-Efficacy. The Generalized Self-Efficacy Scale 17 was included as a global measure of a patients' belief that their actions are responsible for successful outcomes. The global score ranges from 10 to 40.
Depression. Depressive symptomatology was measured with the BDI. 18 Global Symptom Severity. A short version of the SCL-90 19 was included as a measure of global symptom severity. The SCL-K-9 is a 9-item scale with good psychometric properties showing a high correlation (r = 0.93) with the SCL-90 Global Score Index. The SCL-K-9 global score ranges from 0 to 4.
Process Variable Therapy Engagement. Patient engagement was assessed by the therapists on the 2-item, 7-point Likert Scale Effort (range: -3 to +3) of the Bernese Post-Session Report. With the effort scale, therapists are asked to rate patient engagement during the session and between the sessions (through the planning and evaluating of homework tasks, therapists acquire information on how intensively and engaged each patient worked on their goals in real life). The internal consistency of the Therapy Engagement Scale was Cronbach's a = 0.89. Interrater reliability, based on 34 ratings provided by 2 of the therapists, was calculated with 2-way mixed models for random people effects and fixed target effects. The ICC was 0.84 (95%CI, 0.62 to 0.94) at the fifth session, and 0.78 (95%CI, 0.50 to 0.91) at posttreatment.
Procedure
Patient eligibility for group therapy and for the study was evaluated by the therapists during 2 intake sessions. Besides confirming the diagnosis of social anxiety disorder (clinical interview according to DSM-IV criteria for social phobia and LSAS), assessing Axis I and II comorbidity and evaluating the indication and motivation for group treatment, 3 specific therapy goals were defined with each patient. The study was approved by the institutional review board (Zurich, Switzerland, Psychiatry Board) and all participants provided written informed consent.
Patients and therapists completed the assessment measures during the intake and after session 10 (posttreatment). Patient engagement (effort) was rated at sessions 5 and 10, and the individual mean score of the 2 assessment points was used for analyses.
Statistical Analyses
Group comparisons were examined with t tests, univariate ANOVA, and chi-square tests. To test the contribution of pretreatment variables (comorbidity, self-referral, and medication) on therapy outcome, each outcome measure was regressed on each pretreatment variable. Based on these findings, the effect of pretreatment variables was then controlled in later analyses where necessary. General linear models for repeated measures were used to compare outcome between groups (no psychotherapy experience, prior successful therapy, and prior unsuccessful therapy). As the main focus of this study was to compare therapy progress between groups, only group´time interaction effects are reported in the results section.
The predictive ability of the process variable therapy engagement on outcome was first explored with a series of regression analyses using a residualized outcome score as the dependent variable. To be able to perform analyses with the whole sample, therapy history was recoded in 2 dummy variables (success and no success), where patients without therapy history served as the reference group. In the regression analyses, after controlling for the baseline score, therapy history (success and no success) and therapy engagement were entered separately or together.
The impact of therapy engagement in relation to the 5 outcome measures was then tested in an additional set of hierarchical regression analyses for each group (no therapy experience, prior successful therapy, and prior unsuccessful therapy) and for the whole sample as well. To control for patients' pretreatment level of distress, the initial score on each outcome measure being tested was entered in step 1 of the analyses (together with baseline depression levels where necessary). The process variable therapy engagement was then added in step 2.
All significance tests were 2-tailed. Data were analyzed with SPSS 12.0.1 software (SSPS Inc, Chicago, IL).
Results
Pretreatment Variables
A global comparison between patients with and without psychotherapy history showed that the first group was more depressed (BDI: mean 19.0, SD 10.3, compared with mean 12.2, SD 3.4; t = 3.87, df 54, P < 0.001) and more often prescribed psychotropic medication (57%, compared with 27%; ÷ 2 = 4.07, df 1, P < 0.05). On some measures, a general trend toward more severe baseline symptoms was found among patients with prior therapy experience (especially when this was rated as unsuccessful) and shown in Table 1 . However, differences between the 3 groups did not reach statistical significance on any of the symptom measures.
Significant group differences were found concerning comorbidity, where psychotherapy history was more often associated with the presence of comorbid diagnoses. Also, self-referral rates were higher among patients seeking therapy for the first time and lowest among patients with unsuccessful psychotherapy history. Possible effects of pretreatment variables on outcome were tested by regressing each outcome measure on each pretreatment variable. After controlling for pretreatment scores, the variables comorbidity, Axis II comorbidity, self-referral, and medication were not found to be associated with any of the outcome measures. The only exception was found for baseline depression scores, which predicted posttreatment LSAS (R 2 change = 0.05; F change = 4.7, P < 0.05), SCL-K-9 (R 2 change = 0.09; F change = 9.5, P < 0.01) and self-efficacy scores (R 2 change = 0.12; F change = 9.9, P < 0.01).
Dropouts
Dropouts were evenly distributed among the 3 groups (÷ 2 = 0.23, df 2, P > 0.05), showing that therapy history did not differentiate dropouts from completers. 
Posttreatment Outcome
Univariate ANOVA revealed significant group´time effects for anxiety (BAI: F 2, 44 = 3.89, P < 0.05, ç 2 = 0.15) and depression (BDI: F 2, 44 = 3.80, P < 0.05, ç 2 = 0.15). After controlling for initial depression levels, group´time effects were also confirmed for global symptom severity (SCL-K-9: F 2,43 = 4.18, P < 0.05, ç 2 = 0.16). As shown in Figure 1 , patients with a prior history of successful psychotherapy tended to improve the least (stagnation), while patients with negative psychotherapy experience were able to achieve substantial benefits. No significant group´time effects were found for the dependent variables social anxiety (LSAS) and self-efficacy (SE).
Outcome Predictors
Further analyses were carried out to test the predictive ability of pretreatment symptom severity, therapy history, and the process variable therapy engagement.
A first series of regression analyses were performed with the whole sample by using a residualized posttreatment outcome score for the dependent variable. After controlling for the baseline score, therapy history (dummy variables success and no success) and therapy engagement were entered separately or together in the analyses. Results confirmed the predictive value of: psychotherapy history (R 2 change = 0.09, Separate regression analyses for each outcome measure indicated that pretreatment scores were all strong outcome predictors of posttreatment outcome in the whole sample (Table 2) . Interestingly, this relation was found to reach significance among patients with previous (especially positive) therapy experience, while posttreatment symptom level among first-time therapy patients was not associated with initial symptom severity.
Patient therapy engagement (effort) significantly increased outcome prediction in the whole sample and among patients with unsuccessful psychotherapy history, explaining additionally for up to 37% (BDI) of the outcome variance in this subgroup.
Discussion
Our main goal was to examine how psychotherapy history affects short-term cognitive-behavioural group treatment and to explore whether patients with different psychotherapy experiences show different patterns regarding how they benefit from group therapy.
The findings presented, based on a sample of patients undergoing group cognitive-behavioural therapy for social anxiety disorder, support the main hypothesis that experience and satisfaction with previous psychotherapy influence the course of future treatment.
With lower baseline depression scores, less comorbidity, and scarce use of psychotropic medication, patients seeking treatment for the first time showed more favourable pretreatment conditions than patients with repeated psychotherapy experiences. Further, lower self-referral rates were observed among patients who rated prior therapy as unsuccessful, compared with those with positive psychotherapy experience and with new patients. However, after controlling for pretreatment confounding variables, patients with successful therapy history (and not those with unsuccessful therapy experience) were shown to be the ones achieving less favourable outcomes.
Pretreatment symptom severity was confirmed to be a strong outcome predictor for patients with previous treatment history and especially for those with a positive experience, but not for patients seeking therapy for the first time. Therefore, more severely symptomatic patients with successful psychotherapy history seem to be particularly at risk of not benefiting from group therapy. To control for pretreatment levels of depression, the initial BDI score was entered in step 1 of the analyses (together with the pretreatment score on each outcome measure being tested).
b
At a process level in addition to pretreatment symptom severity, patient effort put into therapy was shown to predict outcome only in patients with unsuccessful therapy histories ( Table 2) : in this group, those able to actively work during and between sessions achieved the best results.
In summary, first-time therapy patients were shown to benefit most from group therapy and to be the least vulnerable subgroup in terms of risk factors. Their therapy success was not influenced by pretreatment symptom severity, maybe suggesting a more neutral attitude towards therapy, and a greater ability in letting the therapy process work. It is also possible that through lower comorbidity rates and depression level, this group of patients had more resources to invest in group therapy. Although no group difference was found in terms of self-efficacy at baseline, patients without therapy history were more often self-referred. This could reflect a greater ability in attributing (even small) progress to one's own efforts, which would promote a sense of mastery and facilitate change.
As expected, patients with negative psychotherapy history had partially unfavourable starting conditions. However, results show that they could achieve substantial gains as long as they were able to actively engage and to remain engaged in the therapy process. This does not confirm the assumption that patients with negative psychotherapy experience in the past tend to benefit less from future treatments. It is possible that these patients are disappointed from prior therapists and therefore feel more responsible for clinical improvement, but not all of them find a way of actively modifying their situation. From a clinical point of view, the relevance of the process variable therapy engagement suggests that in this group of patients it may be particularly important to reinforce their initiative, to support possibilities to actively engage, and to openly discuss reasons for not engaging.
Surprisingly, patients with successful therapy history were the ones benefiting the least from group therapy. As shown in Figure 1 , these patients seemed to stagnate or to progress very slowly. In contrast to other patients, their outcome was mostly influenced by initial symptom severity, while the process variable therapy engagement did not significantly affect clinical improvement. It is possible that for some of these patients with positive prior experience the current therapy proved to be a relative disappointment, translating into poorer outcome. The unexpected findings concerning first-time therapy patients also raise the questions of how successful their prior therapies were in actuality, and whether the subjectivity of the success ratings constituted a bias. The hypothesis can be made that some of these patients might have been driven by loyalty feelings towards their prior therapist and did not want to question his or her ability or efficacy; maybe preferring to blame themselves instead of their therapist, or the therapy process. Another possibility is that some of the subjects might have provided a socially desirable response to show that they are good or acceptable patients to the current therapist. It may be the case that such tendencies are particularly accentuated among patients with social anxiety disorder, characterized by the effort to please or at least not to disappoint others, by dependence from other people's opinions and by impaired self-efficacy. By putting their efforts into impression management, some patients might have tried to keep their rejection anxiety at a tolerable level. This assumption is consistent with the lack of predictive power of concrete engagement for clinical improvement in the subgroup of patients with positive psychotherapy history, possibly reflecting a stronger need for a trustful therapeutic relationship rather than a need for mastery such as in the group of patients with negative experiences. Additional process variables including therapeutic alliance might have been relevant for testing this interpretation and should be included in future studies on this topic.
Some practical implications can be drawn from the findings concerning the particular group of patients rating previous therapies as successful. First, it seems particularly important for clinicians to carefully assess not only past therapy failures but also to explore the reasons why a patient with successful therapy history seeks a new treatment. It may be essential for these patients to get the opportunity to openly talk about previous therapy processes and to discuss their attitudes and expectations towards future treatments or therapists. Secondly, therapists should be particularly vigilant in regularly and critically checking with this group of patients on how they experience the therapy process.
Some limitations in our study should be considered as well.
The main one is that our sample of patients with psychotherapy history does not represent those patients who attempted therapy before. As we have no information on those who chose not to try therapy again, our sample may differ from the entireness of patients with previous experience concerning motivation, self-efficacy, and maybe better support through their family or primary care physician in being encouraged for a new therapy attempt. A prospective study focusing on future usage of psychotherapy among all patients with psychotherapy history could complement the results presented here. Further, this study is based on a sample of individuals with social phobias undergoing cognitive-behavioural group therapy. Future research should assess whether the presented findings can be generalized to other diagnostic groups and whether similar patterns can be confirmed for individual therapy. Finally, it might be worth improving the specificity of the central variable previous therapy experience in future studies. Assessing the kind of previous therapy (including details on orientation, setting, and length) could provide further information on the differential impact of specific successful, compared with unsuccessful therapy forms. Additionally, the inclusion of broader success ratings (for example, based on 5-or 7-point scales) would allow analyses of the whole sample and result in increased power.
Our study confirms that patients seeking therapy for the first time tend to benefit more from group therapy, and that it is essential to differentiate between types of prior therapy experience. While patients with negative experiences seem to need special support in increasing their active therapy engagement, patients rating previous therapies as successful may need specific pretreatment assessments and a more careful focus on the therapeutic relationships.
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Résumé : Une expérience de psychothérapie antérieure affecte-t-elle le cours d'une thérapie de groupe cognitivo-comportementale pour le trouble d'anxiété sociale?
Objectif : Examiner si les différents modèles d'antécédents de psychothérapie (pas de thérapie antérieure, expérience réussie de thérapie, et expérience de thérapie sans succès) affectent le résultat d'un futur traitement chez les patients d'une thérapie de groupe cognitivo-comportementale pour le trouble d'anxiété sociale, et le cas échéant, de quelle manière.
Méthode : Cinquante-sept patients ayant divers antécédents de psychothérapie et participant à un traitement de groupe cognitivo-comportemental pour le trouble d'anxiété sociale ont été inclus dans l'étude. La gravité des symptômes (dont l'anxiété, la dépression, l'auto-efficacité et la gravité générale des symptômes) a été évaluée avant et après le traitement. Une mesure par le thérapeute de l'engagement du patient à la thérapie était incluse à titre de variable du processus.
Résultats :
Les patients en thérapie pour la première fois présentaient des variables prétraitement plus favorables et tiraient meilleur profit de la thérapie de groupe. Chez les patients ayant eu une expérience de thérapie sans succès, des gains substantiels ont été obtenus par ceux qui étaient capables de s'engager activement au processus thérapeutique. Les patients ayant estimé les thérapies antérieures réussies étaient ceux qui en bénéficiaient le moins et tendaient à stagner. Des explications possibles des différences entre les groupes et des implications cliniques sont présentées.
Conclusions : L'expérience antérieure de psychothérapie affecte le cours de la thérapie de groupe cognitivo-comportementale chez les patients souffrant de phobie sociale. Alors que les patients ayant eu une expérience de thérapie négative peuvent avoir grand besoin d'aide pour s'engager activement et le demeurer, ceux qui estiment que leurs thérapies antérieures ont été réussies doivent être évalués très attentivement et peuvent bénéficier d'un fort accent
